Maktaba

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Does walking during chemotherapy impact p16 INK4a levels in women with early breast cancer.

Authors : Kammire MS; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Deal AM

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy; Humans ; Female

Source: Journal of clinical laboratory analysis [J Clin Lab Anal] 2022 Dec; Vol. 36 (12), pp. e24753. Date of Electronic Publication: 2022 Nov 06.Publisher: Wiley Country of Publication: United States NLM ID: 8801384 Publication Model: Print-Electronic Cited Medium:

Record details

Read Online Read More Add to Saved list

Academic Journal

Utility of routine pretreatment evaluation of left ventricular ejection fraction in breast cancer patients receiving anthracyclines.

Authors : Peddi P; Department of Medicine, Division of Hematology and Oncology, Louisiana State University Health Science Center-Shreveport, Shreveport, Louisiana.; Master SR

Subjects: Anthracyclines/Anthracyclines/Anthracyclines/*adverse effects ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*adverse effects ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy

Source: The breast journal [Breast J] 2019 Jan; Vol. 25 (1), pp. 62-68. Date of Electronic Publication: 2018 Dec 27.Publisher: Wiley Country of Publication: United States NLM ID: 9505539 Publication Model: Print-Electronic Cited Medium:

Record details

Read Online Read More Add to Saved list

Academic Journal

Mass spectrometric approaches for the identification of anthracycline analogs produced by actinobacteria.

Authors : Bauermeister A; Mass Spectrometry Applied to Natural Products Laboratory, Departamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo, CEP: 14040-901, Ribeirão Preto, SP, Brazil.; Zucchi TD

Subjects: Actinobacteria/Actinobacteria/Actinobacteria/*chemistry ; Anthracyclines/Anthracyclines/Anthracyclines/*analysis ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*analysis

Source: Journal of mass spectrometry : JMS [J Mass Spectrom] 2016 Jun; Vol. 51 (6), pp. 437-45.Publisher: Wiley Country of Publication: England NLM ID: 9504818 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list

Academic Journal

Evaluation of cardiotoxicity of anthracycline‐containing chemotherapy regimens in patients with bone and soft tissue sarcomas: A study of the FDA adverse event reporting system joint single‐center real‐world experience

Authors : Zeming Mo; Yaotiao Deng; Yiwen Bao

Subjects: ADM; anthracyclines; bone and soft tissue sarcomas

Source: Cancer Medicine, Vol 12, Iss 24, Pp 21709-21724 (2023)

Record details

Read Online Read More Add to Saved list

Academic Journal

Beneficial Effects of Oral Carbon Monoxide on Doxorubicin‐Induced Cardiotoxicity

Authors : Rodrigo W. Alves de Souza; Vanessa Voltarelli; David Gallo

Subjects: anthracyclines; cancer; carbon monoxide

Source: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 9 (2024)

Record details

Read Online Read More Add to Saved list

Academic Journal

Myocardial dysfunction in long-term breast cancer survivors treated at ages 40-50 years.

Authors : Jacobse JN; Department of Epidemiology & Biostatistics, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Steggink LC

Subjects: Cancer Survivors* ; Heart Failure*/Heart Failure*/Heart Failure*/epidemiology ; Ventricular Dysfunction, Left*/Ventricular Dysfunction, Left*/Ventricular Dysfunction, Left*/chemically induced

Source: European journal of heart failure [Eur J Heart Fail] 2020 Feb; Vol. 22 (2), pp. 338-346. Date of Electronic Publication: 2019 Nov 06.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

Read Online Read More Add to Saved list

Academic Journal

Heart failure after treatment for breast cancer.

Authors : Boekel NB; Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Duane FK

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/epidemiology ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/radiotherapy

Source: European journal of heart failure [Eur J Heart Fail] 2020 Feb; Vol. 22 (2), pp. 366-374. Date of Electronic Publication: 2019 Nov 12.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

Read Online Read More Add to Saved list

Academic Journal

The role of irradiated heart and left ventricular volumes in heart failure occurrence after childhood cancer.

Authors : Mansouri I; CESP, Université Paris-Saclay, Villejuif, France.; CESP, INSERM U 1018, Cancer and Radiation team, Gustave Roussy, Villejuif, France.

Subjects: Cardiac Volume/Cardiac Volume/Cardiac Volume/*radiation effects ; Cardiotoxicity/Cardiotoxicity/Cardiotoxicity/*physiopathology ; Heart/Heart/Heart/*radiation effects

Source: European journal of heart failure [Eur J Heart Fail] 2019 Apr; Vol. 21 (4), pp. 509-518. Date of Electronic Publication: 2018 Dec 27.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

Read Online Read More Add to Saved list

Academic Journal

Enhanced anti-tumour effects of Vinca alkaloids given separately from cytostatic therapies.

Authors : Ehrhardt H; Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany.; Pannert L

Subjects: Anthracyclines/Anthracyclines/Anthracyclines/*pharmacology ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Dexamethasone/Dexamethasone/Dexamethasone/*pharmacology

Source: British journal of pharmacology [Br J Pharmacol] 2013 Apr; Vol. 168 (7), pp. 1558-69.Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list

Academic Journal

Chronic cardiotoxicity of anticancer anthracyclines in the rat: role of secondary metabolites and reduced toxicity by a novel anthracycline with impaired metabolite formation and reactivity.

Authors : Sacco G; Menarini Ricerche S.pA., ViaTito Speri 10, 00040 Pomezia, Rome, Italy.; Giampietro R

Subjects: Anthracyclines/Anthracyclines/Anthracyclines/*metabolism ; Anthracyclines/Anthracyclines/Anthracyclines/*toxicity ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*metabolism

Source: British journal of pharmacology [Br J Pharmacol] 2003 Jun; Vol. 139 (3), pp. 641-51.Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print Cited Medium: Print ISSN:

Record details

Read Online Read More Add to Saved list

Search Results

Your Filters

Does walking during chemotherapy impact p16 INK4a levels in women with early breast cancer.

Utility of routine pretreatment evaluation of left ventricular ejection fraction in breast cancer patients receiving anthracyclines.

Mass spectrometric approaches for the identification of anthracycline analogs produced by actinobacteria.

Evaluation of cardiotoxicity of anthracycline‐containing chemotherapy regimens in patients with bone and soft tissue sarcomas: A study of the FDA adverse event reporting system joint single‐center real‐world experience

Beneficial Effects of Oral Carbon Monoxide on Doxorubicin‐Induced Cardiotoxicity

Myocardial dysfunction in long-term breast cancer survivors treated at ages 40-50 years.

Heart failure after treatment for breast cancer.

The role of irradiated heart and left ventricular volumes in heart failure occurrence after childhood cancer.

Enhanced anti-tumour effects of Vinca alkaloids given separately from cytostatic therapies.

Chronic cardiotoxicity of anticancer anthracyclines in the rat: role of secondary metabolites and reduced toxicity by a novel anthracycline with impaired metabolite formation and reactivity.